CogState Limited (ASX: CGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CogState Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CogState Limited (ASX: CGS)
Latest News
Share Gainers
Why the CogState (ASX:CGS) share price is rocketing 36% higher today
Share Market News
Why the Cogstate share price soared 78% higher today
Share Market News
ALL ORDINARIES finishes lower Friday: 8 ASX shares you missed
Share Gainers
Why the CogState share price is surging higher today
Share Gainers
ALL ORDINARIES finishes higher Wednesday: 8 shares you missed
Share Market News
Why the Cogstate share price tumbled today
Share Gainers
These small caps shares have stormed higher on Wednesday
Share Market News
ALL ORDINARIES finishes lower Monday: 10 shares you missed
Share Market News
The CogState Limited share price rebounds on profit report
Share Market News
ALL ORDINARIES finishes higher Friday: 8 shares you missed
Share Market News
CogState Limited shares fall on profit guidance update
Healthcare Shares
3 small cap healthcare shares on my watchlist
Frequently Asked Questions
-
No, Cogstate does not pay dividends at this stage.
-
Cogstate Ltd listed on the ASX on 13 February 2004.
CGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CogState Limited
Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.
The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment.
Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.
